273 related articles for article (PubMed ID: 15928314)
21. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
22. Activation of phosphatidylinositol 3-kinase/Akt signaling by EGF downregulates membranous E-cadherin and β-catenin and enhances invasion in nasopharyngeal carcinoma cells.
Yip WK; Seow HF
Cancer Lett; 2012 May; 318(2):162-72. PubMed ID: 22182447
[TBL] [Abstract][Full Text] [Related]
23. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
24. A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo.
Rajput A; Koterba AP; Kreisberg JI; Foster JM; Willson JK; Brattain MG
Cancer Res; 2007 Jan; 67(2):665-73. PubMed ID: 17234777
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells.
De Santis G; Miotti S; Mazzi M; Canevari S; Tomassetti A
Oncogene; 2009 Mar; 28(9):1206-17. PubMed ID: 19151754
[TBL] [Abstract][Full Text] [Related]
26. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
[TBL] [Abstract][Full Text] [Related]
27. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
28. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
Lau MT; Klausen C; Leung PC
Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
[TBL] [Abstract][Full Text] [Related]
29. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
Rieger-Christ KM; Lee P; Zagha R; Kosakowski M; Moinzadeh A; Stoffel J; Ben-Ze'ev A; Libertino JA; Summerhayes IC
Oncogene; 2004 Jun; 23(27):4745-53. PubMed ID: 15122336
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression.
Cheng JC; Chang HM; Leung PC
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1380-9. PubMed ID: 22569238
[TBL] [Abstract][Full Text] [Related]
31. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
Cheng JC; Chang HM; Xiong S; So WK; Leung PC
Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
[TBL] [Abstract][Full Text] [Related]
32. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling.
Brouxhon SM; Kyrkanides S; Teng X; Athar M; Ghazizadeh S; Simon M; O'Banion MK; Ma L
Oncogene; 2014 Jan; 33(2):225-35. PubMed ID: 23318419
[TBL] [Abstract][Full Text] [Related]
33. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
[TBL] [Abstract][Full Text] [Related]
34. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells.
Hofmann C; Obermeier F; Artinger M; Hausmann M; Falk W; Schoelmerich J; Rogler G; Grossmann J
Gastroenterology; 2007 Feb; 132(2):587-600. PubMed ID: 17258732
[TBL] [Abstract][Full Text] [Related]
35. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells.
Cheng JC; Chang HM; Leung PC
Oncogene; 2013 Feb; 32(8):1041-9. PubMed ID: 22508482
[TBL] [Abstract][Full Text] [Related]
36. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor.
Shen X; Kramer RH
Am J Pathol; 2004 Oct; 165(4):1315-29. PubMed ID: 15466396
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
[TBL] [Abstract][Full Text] [Related]
39. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
Cheng JC; Auersperg N; Leung PC
Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]